Company Filing History:
6 out of 3,685 
4 out of 1,927 
1 out of 832,718 Years Active: 2017-2025
Title: Exploring the Innovations of Konstantinos Konstantopoulos
Introduction
Konstantinos Konstantopoulos, based in Ellicott City, Maryland, is a distinguished inventor with a remarkable portfolio of six patents. His work primarily focuses on advancements in the field of cancer research, specifically in analyzing cell motility and improving personalized therapy approaches.
Latest Patents
Two of his latest patents reflect his innovative spirit and dedication to oncology. The first patent, titled "Microfluidic chip for analysis of cell motility and methods for using same," presents an integrated apparatus designed for the identification of migratory cells directly from specimens. This technology requires only a small number of cells to conduct assays. Notable features of this apparatus include unique topographic designs that effectively differentiate between migratory and non-migratory cell populations. This invention is particularly valuable for assessing the spontaneous and chemotactic migration of cancer cells, allowing for the identification and characterization of tumor subpopulations. Furthermore, it enables the evaluation of treatment strategies with chemotherapeutic agents aimed at inhibiting cell migration, with an emphasis on personalized therapies based on patient-specific factors.
Konstantopoulos's second patent, "Use of an integrated microfluidic chip for analysis of cell motility and prediction and prognosis of patient survival," expands on these themes. It facilitates the identification of invasive tumor cells and employs methods that predict cancer survivability and the risk of recurrence following treatment. By utilizing the apparatus, researchers can determine the most effective therapeutic strategies and mitigate the invasiveness of tumor cells, laying the groundwork for customized treatment plans. This invention embodies a significant step toward improving patient outcomes in cancer care.
Career Highlights
Throughout his career, Konstantinos has aligned himself with prestigious research institutions, notably The Johns Hopkins University and the University System of Maryland. His work in these environments has allowed him to push the boundaries of cancer research, contributing to significant advancements in tumor analysis and treatment strategies.
Collaborations
Konstantinos has collaborated with notable professionals in the field, including Colin Dowlin Paul and Alfredo Quinones-Hinojosa. These associations have fostered a collaborative spirit that enhances research excellence and innovation in oncology.
Conclusion
The contributions of Konstantinos Konstantopoulos to the field of cancer research highlight the importance of innovation in medical science. His advanced patents represent a fusion of technology and biology, poised to revolutionize how tumors are analyzed and treated. With his commitment to improving patient survival rates through innovative therapies, Konstantopoulos stands as a key figure in the ongoing fight against cancer.